Resp. bio expansion

Quote




anonymous said:
Third to market and Dupixent is also coming soon. Should be exciting competing against Respiratory powerhouse GSK. Not feeling good about having this many reps on board. If the sales aren’t strong right away we will have layoffs. That’s how we roll!
Click to expand...

Fasenra is the 4th to market biologic in the moderate to severe asthma space after Xolair, Nucala, and Cinqair. All are administered in clinic. Fasenra has marginal efficacy compared to Nucala and Cinqair. Also, the every 2 month dosing for Fasenra may not be an advantage as reduced clinic visits mean less income to administer it. Marketing Fasenra is going to be a challenge.
 



anonymous said:
With the shit show of realigned territories that they just fucked the Fasenra sales teams with I'm sure there will be more openings soon. Myself included.
Click to expand...

Hey, Sanofi / Regeneron sales force openings for their new severe asthma injectible will be posted tomorrow 3/9, I'm sure there will be plenty of room for your sorry ass over there.
 



anonymous said:
Third to market and Dupixent is also coming soon. Should be exciting competing against Respiratory powerhouse GSK. Not feeling good about having this many reps on board. If the sales aren’t strong right away we will have layoffs. That’s how we roll!
Click to expand...


We'll need all the reps we can get plus some, in order to compete with Dupixent. It's going to be a game changer and with all the reps they are bringing on between Regeneron and Sanofi, this will now become a very crowded market.
 






anonymous said:
Fasenra is the 4th to market biologic in the moderate to severe asthma space after Xolair, Nucala, and Cinqair. All are administered in clinic. Fasenra has marginal efficacy compared to Nucala and Cinqair. Also, the every 2 month dosing for Fasenra may not be an advantage as reduced clinic visits mean less income to administer it. Marketing Fasenra is going to be a challenge.
Click to expand...

"Reduced clinic visits" ? The key to the game is new patient starts. Residual treatments baby!!!
 






anonymous said:
Well, all the ex Novartis/Genentech managers and reps will surely save AZ...?? Don't worry they will make sure everything is ok because they ARE the smartest people in industry. Remember they all came to AZ to save and create the ultimate bio field force led by incredible geniuses, there is no way they will let their gravy train come to an end, however, those at NV (at least) would like to thank them for all the raises and stock received as result of them leaving.

Enjoy that deep pipeline with so many resp products....um... I mean 1 product.
Click to expand...

Bitter much? Ever heard of Tezepelumab? You know the other biologic in the pipeline I guess it’s easier just being bitter. Genius. The real geniuses are all of you complacent Big Pharma I’ll stay forever and get mad when I don’t have the skills for an upward move.
 



AZ has a terrible culture! Pressure cooker during launches. Little tolerance for underperformance. Performance improvement plans if you are not hitting the mark 6 months after launch.
 



anonymous said:
If you don’t know how to slam-dunk sell Fasenra vs Xolair, Nucala, & Cinqair, then that is why you’re not good enough to get this job.
Click to expand...


We'll see how much "slam dunking" you'll be doing when Dupixant is launched. Get in the back of the line because there won't be any scripts left for you. Then you will be looking for a job at Sanofi or Regeneron.
 



anonymous said:
We'll see how much "slam dunking" you'll be doing when Dupixant is launched. Get in the back of the line because there won't be any scripts left for you. Then you will be looking for a job at Sanofi or Regeneron.
Click to expand...

Dupixent will go as well as well as all of their other launches! You do realize how many Regeneron people came here, right?
 









I interviewed for this position recently still haven’t heard anything at all!
The anticipation is building- do they let you know? I’ve called the interviewing manager four times and go straight to VM!
Is that how this company tells you? Where is the formality?
 






If you haven't been invited to a final interview with the regional manager by now, you have been passed over.
I hate that AZ is treating candidates this way and is not informing people that they are not moving forward, but this seems to be industry standard. Even internal candidates have been left hanging, not cool.
 






just look outside the box. AZ has always been a follower. they are trying to rescue the current do not know nothing reps. it takes 3 az reps to do one job. all they know is how to sound good act like they are working but realy doing nothing. az will never succeed in anything untill they realy start making thier managers n reps actually work real work
 









Top Bottom
Back
Quote